By Morgan Bettex ( July 23, 2009, 4:22 PM EDT) -- In an effort to secure a top position in the biologics industry, Bristol-Myers Squibb Co. has agreed to buy Medarex Inc., which develops human antibody-based therapeutics to treat life-threatening diseases, in a $2.1 billion deal that gives the drug giant full ownership rights to a promising treatment for melanoma....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.